article thumbnail

Ipsen plans sale of consumer health business for €350m

pharmaphorum

Privately-held Mayoly Spindler is a specialist in gastroenterology and dermato-cosmetic products that has set itself the target of becoming a top 10 European OTC medicines company in the next 10 years. The post Ipsen plans sale of consumer health business for €350m appeared first on. billion takeover of Clementia Pharma in 2019.

Sales 103
article thumbnail

Scorpion inks deal with Pierre Fabre for next-gen EGFR inhibitors

Pharmaceutical Technology

On April 4, Scorpion Therapeutics announced a collaboration and license agreement with the French dermo-cosmetic and pharmaceutical group Pierre Fabre to codevelop two next-generation epidermal growth factor receptor (EGFR) inhibitors. According to GlobalData’s Pharma Intelligence Centre, Tagrisso is forecasted to have global sales of $8.19

Cosmetics 130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Some Talc Products Contain Asbestos: Study

The Pharma Data

30, 2020 – Nearly 15% of talc-based cosmetic products analyzed in a recent study contained asbestos. Environmental Working Group (EWG) — an American advocacy nonprofit that commissioned the tests and did the analysis — said methods used by the cosmetics industry to screen talc supplies are inadequate. MONDAY, Nov.

article thumbnail

Top 20 Best-Selling Neurology Drugs to Watch in 2024

XTalks

In this blog, we highlight the top 20 best-selling neurology drugs to watch in 2024, based on 2023 sales statistics. We discuss each drug’s approved uses, sales performance and why they’ve become essential in the neurology space. Related: Top 30 Drugs to Watch in 2024: Insights from 2023 Sales Data 1. billion in the US and $4.1

article thumbnail

FDA Cracks Down on Company Falsely Promoting COVID-19-Curing Teas

XTalks

The letter , which was sent on January 4, 2021, stated that several of the company’s products violated section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. § 355(a) which prohibits the introduction and delivery of new drugs without the Secretary of Health of Human Service’s approval.

article thumbnail

Seize the Night and Day: Examining Indorsia’s Insomnia Campaign Featuring Jennifer Aniston

XTalks

In light of the market size for this indication, Quviviq’s initial sales numbers may seem underwhelming. But Indorsia explains that the net sales “do not reflect the volume as broad commercial coverage is under negotiation.” The global insomnia market was worth an estimated $5.1 billion in 2022. billion during the same period.

article thumbnail

The FDA and Customs and Border Protection Bust Illegal E-Cigarette Shipment

XTalks

This includes some flavored e-cigarettes imported to the US that do not meet Federal Food, Drug and Cosmetic Act (FD&C Act) requirements, as amended by the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act).